Literature DB >> 11012987

Angiomatoid (malignant) fibrous histiocytoma: a peculiar low-grade tumor showing immunophenotypic heterogeneity and ultrastructural variations.

T Hasegawa1, K Seki, K Ono, S Hirohashi.   

Abstract

To clarify the cellular differentiation features and facilitate diagnosis of angiomatoid (malignant) fibrous histiocytoma (AFH), four cases of AFH were examined by clinicopathologic, immunohistochemical and ultrastructural analyses. The age of the patients ranged from 10 to 24 years (mean, 17 years) and the sex distribution was equal. All cases were of subcutaneous origin: three arose in the trunk and one in the upper extremity. All patients presented with systemic symptoms, including inflammatory signs and anemia. After a mean follow up of 11 years 3 months, all patients were alive and well, although one patient twice developed local recurrence after surgery. All cases presented as multinodular, cystic and hemorrhagic tumors ranging in size from 4 to 11 cm (mean, 8 cm) and were characterized by sheets of bland spindle or round cells with oval nuclei within a circumscribed nodule often surrounded by a lymphocytic cuff. One tumor showed predominantly round cell morphology similar to Ewing's sarcoma/primitive neuroectodermal tumor. All cases (100%) exhibited immunoreactivity for vimentin, desmin, CD68 and CD57 (Leu-7). Three cases (75%) were positive for synaptophysin, and reactivity for alpha-smooth muscle actin, epithelial membrane antigen, neuron-specific enolase and CD99 (O-13) was present in two cases (50%) each. The three cases examined by electron microscopy had a mixture of fibrohistiocytic, myofibroblastic and undifferentiated cells containing cytoplasmic processes and dense-core granules. It is important for accurate diagnosis of this peculiar soft-tissue tumor to recognize that it has a variety of immunophenotypes, such as histiocytic, myofibroblastic, epithelial and neural, and may occasionally have a predominantly round cell morphology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012987     DOI: 10.1046/j.1440-1827.2000.01112.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  8 in total

1.  Angiomatoid fibrous histiocytoma: novel MR imaging findings.

Authors:  Salutario J Martinez; Courtney Coursey Moreno; Emily N Vinson; Leslie G Dodd; Brian E Brigman
Journal:  Skeletal Radiol       Date:  2016-02-27       Impact factor: 2.199

2.  Retroperitoneal malignant fibrous histiocytoma mimicking pheochromocytoma.

Authors:  Sandra Pekic; Svetozar Damjanovic; Marina Djurovic; Mirjana Doknic; Milan Petakov; Dragana Miljic; Zorka Milovanovic; Kalman Kovacs; Vera Popovic
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

3.  Angiomatoid fibrous histiocytoma in a 25-year-old male.

Authors:  Aaron Mansfield; Brenda Larson; Scott L Stafford; Thomas C Shives; Michael G Haddock; David Dingli
Journal:  Rare Tumors       Date:  2010-06-30

Review 4.  Recurrent painful perianal subcutaneous angiomatoid fibrous histiocytoma: a case report and review of the literature.

Authors:  Xiangyi Kong; Dachun Zhao; Guole Lin; Jiaolin Zhou; Quancai Cui
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

Review 5.  Angiomatoid fibrous histiocytoma: a series of seven cases including genetically confirmed aggressive cases and a literature review.

Authors:  Kenichi Saito; Eisuke Kobayashi; Akihiko Yoshida; Yoshihiro Araki; Daisuke Kubota; Yoshikazu Tanzawa; Akira Kawai; Takashi Yanagawa; Kenji Takagishi; Hirokazu Chuman
Journal:  BMC Musculoskelet Disord       Date:  2017-01-23       Impact factor: 2.362

6.  Subcutaneous angiomatoid fibrous histiocytoma mimicking metastatic melanoma.

Authors:  E Sparreboom; C Wetzels; M Verdijk; S Mulder; W Blokx
Journal:  Case Rep Pathol       Date:  2012-12-20

7.  Molecular approaches to sarcoma therapy.

Authors:  R J Olsen; S R Tarantolo; S H Hinrichs
Journal:  Sarcoma       Date:  2002

8.  An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts.

Authors:  Arnault Tauziède-Espariat; Philipp Sievers; Frédérique Larousserie; Joseph Benzakoun; Delphine Guillemot; Gaëlle Pierron; Mathilde Duchesne; Emmanuelle Uro-Coste; Alexandre Roux; Alexandre Vasiljevic; Tanguy Fenouil; David Meyronet; Karima Mokhtari; Marc Polivka; Audrey Rousseau; Frédérique Bost-Bezeaud; Samir Akoury; Johan Pallud; Chiara Benevello; Lauren Hasty; Albane Gareton; Emmanuèle Lechapt; Fabrice Chrétien; Thomas Blauwblomme; Kévin Beccaria; Stéphanie Puget; Felix Sahm; Pascale Varlet
Journal:  Brain Pathol       Date:  2021-07-27       Impact factor: 6.508

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.